Cargando…
Correction: Mehrling, T.; et al. Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy. Antibodies 2018, 7, 11
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640681/ https://www.ncbi.nlm.nih.gov/pubmed/31544883 http://dx.doi.org/10.3390/antib7030032 |
| _version_ | 1783436621678379008 |
|---|---|
| author | Mehrling, Thomas Soltis, Daniel |
| author_facet | Mehrling, Thomas Soltis, Daniel |
| author_sort | Mehrling, Thomas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6640681 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66406812019-09-05 Correction: Mehrling, T.; et al. Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy. Antibodies 2018, 7, 11 Mehrling, Thomas Soltis, Daniel Antibodies (Basel) Correction MDPI 2018-08-27 /pmc/articles/PMC6640681/ /pubmed/31544883 http://dx.doi.org/10.3390/antib7030032 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Mehrling, Thomas Soltis, Daniel Correction: Mehrling, T.; et al. Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy. Antibodies 2018, 7, 11 |
| title | Correction: Mehrling, T.; et al. Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy. Antibodies 2018, 7, 11 |
| title_full | Correction: Mehrling, T.; et al. Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy. Antibodies 2018, 7, 11 |
| title_fullStr | Correction: Mehrling, T.; et al. Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy. Antibodies 2018, 7, 11 |
| title_full_unstemmed | Correction: Mehrling, T.; et al. Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy. Antibodies 2018, 7, 11 |
| title_short | Correction: Mehrling, T.; et al. Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy. Antibodies 2018, 7, 11 |
| title_sort | correction: mehrling, t.; et al. challenges in optimising the successful construction of antibody drug conjugates in cancer therapy. antibodies 2018, 7, 11 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640681/ https://www.ncbi.nlm.nih.gov/pubmed/31544883 http://dx.doi.org/10.3390/antib7030032 |
| work_keys_str_mv | AT mehrlingthomas correctionmehrlingtetalchallengesinoptimisingthesuccessfulconstructionofantibodydrugconjugatesincancertherapyantibodies2018711 AT soltisdaniel correctionmehrlingtetalchallengesinoptimisingthesuccessfulconstructionofantibodydrugconjugatesincancertherapyantibodies2018711 AT correctionmehrlingtetalchallengesinoptimisingthesuccessfulconstructionofantibodydrugconjugatesincancertherapyantibodies2018711 |